Valerie P. Grignol - Concepedia

Author

Valerie P. Grignol

Also Known As

Chandler D., David Konieczkowski, V Grignol, V. Grignol, V. P. Grignol, V.P. Grignol, VALERIE GRIGNOL, Valerie Grignol, Valerie P Grignol, Valerie P. Grignol

130

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Emory University Stanford University Wake Forest University Medical College of Wisconsin

About

Valerie P. Grignol is an author at The Ohio State University specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	404
2	Cell Biology	3	3	186
3	Biomedical Engineering	2	2	33
4	Engineering	1	1	17
5	Cellular Therapies	1	1	16

Valerie P. Grignol

Publications

Citations

H-Index

Page 1

	Year	Citations
MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor Sara E. Martin del Campo, Nicholas Latchana, Kala Levine, PLoS ONE ImmunologyCancer BiologyTumor BiologyOncologyMir-21 Inhibitor	2015	104
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions Valerie P. Grignol, Ene T. Fairchild, Jason M. Zimmerer, British Journal of Cancer	2011	76
Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy Valerie P. Grignol, Andrew D. Smith, Darya P. Shlapak, Surgical Oncology Subcutaneous Fat RatioMedicineMelanomaPathologyMetastatic Melanoma	2015	71
Interleukin-29 Binds to Melanoma Cells Inducing Jak-STAT Signal Transduction and Apoptosis Kristan Guenterberg, Valerie P. Grignol, Ene T. Raig, Molecular Cancer Therapeutics ImmunologyImmunoeditingCell DeathPathologyImmunologic Mechanism	2010	50
Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group William W. Tseng, Francesco Barretta, Lorenzo Conti, Cancer	2020	47
A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma Valerie P. Grignol, Thomas Olencki, Kiran Relekar, Journal of Immunotherapy MedicineMelanomaImmunologyCancer GrowthMetastatic Melanoma	2011	46
Role of radiation therapy for retroperitoneal sarcomas: An eight‐institution study from the US Sarcoma Collaborative Konstantinos Chouliaras, Rebecca Senehi, Cecilia G. Ethun, Journal of Surgical Oncology	2019	38
<i>MDM2</i> Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes Lucia Casadei, Federica Calore, Danielle Braggio, Cancer Research	2019	37
Recurrence patterns after resection of retroperitoneal sarcomas: An eight‐institution study from the US Sarcoma Collaborative Konstantinos Chouliaras, Rebecca Senehi, Cecilia G. Ethun, Journal of Surgical Oncology	2019	35
Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi‐institutional analysis of the US Sarcoma Collaborative Jason T. Wiseman, Cecilia G. Ethun, Jordan M. Cloyd, Journal of Surgical Oncology	2020	35

Page 1